Sterilisation services provider Sterigenics is building a new facility in the UK, the company has announced.
Expansion
Sterigenics’ new site will be based in Chesterfield/Derbyshire and will help the company meet the growing demand for sterilisation services in Europe. The facility, which is expected to be completed at the end of this year, will add gamma sterilisation capabilities to complement Sterigenics’ existing ethylene oxide (EtO) facility based in Somercotes/Derbyshire. More so, the facility will expand Sterigenics’ total gamma irradiation capacity in Europe, adding to existing gamma facilities located in Belgium and Italy.
President of Sterigenics, Philip Macnabb, said: “Sterigenics is committed to being the world’s leading provider of sterilisation services and partnering with our customers to eliminate threats to human health. We continue to invest in our global network to meet our customers’ growing demand for gamma irradiation capacity as a critical step in their product development processes. Our new Markham Vale facility will strengthen our ability to serve our European customers, particularly in the MedTech and pharmaceutical fields, and help them innovate with success.”
Over the past few years, Sterigenics has made significant investments in technology to expand both gamma and ethylene oxide (EtO) sterilisation capacity throughout its global network.
“Our Markham Vale North facility is strategically located to serve the needs of our European customers,” said Adrian Wye, director of UK Operations. “Its prime location at the heart of the UK’s motorway network will provide an optimum location for their supply chain logistics. And our facility’s high-tech capabilities will deliver the turnaround times necessary to distribute their products to market quickly.”